Short Communication
Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea

Hamideh Azimi, Effat Khodaeiani and Mohamad Goldust

Journal of Biological Sciences, 2013, 13(8), 727-731.


This study aimed at evaluating the efficacy of oral erythromycin in patients with Pityriasis Rosea. Fifty patients were selected which were the divided into 2 groups. In group A (test group) the patients were treated by erythromycin while in group B (plecebo group) the patients received chlorpheniramin or diphenhydramin. Complete response was observed in 16 patients (64%) in the treatment group (A) and none in the second group (B) (p = 0/0001). It is recommended to treat the patients suffering from pityriasis rosea at any time of disease diagnosis using oral erythromycin for a two-week period.

ASCI-ID: 38-2261

Cited References Fulltext

Similar Articles

Glanders-A Re-emerging Zoonotic Disease: A Review

Journal of Biological Sciences, 2014, 14(1), 38-51.

Ashwagandha (Withania somnifera): Role in Safeguarding Health, Immunomodulatory Effects, Combating Infections and Therapeutic Applications: A Review

Journal of Biological Sciences, 2014, 14(2), 77-94.

Treatment of Feline panleukopenia Virus Infection in Naturally Infected Cats and its Assessment

Journal of Biological Sciences, 2019, 19(2), 155-160.